Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-07

Clinical Trial Update: Dexmedetomidine to Treat Bariatric Surgery-associated Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating dexmedetomidine for treating bariatric surgery-associated pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Janelle Vaughns | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2021-12-07